Japan's Takeda is considering a bid for Shire, a rival drug maker valued at around $40 billionhttps://on.wsj.com/2IbRW9T
0 replies
20 retweets
27 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.